Cellectar Biosciences Announces Closing Of Up To Approximately $103 Million Private Placement Financing
Amount Raised
$103 Million
Round Type
Post-IPO Equity
Florham ParkBiotechnologyHealthcarePharmaceuticalBiopharmaDescription
Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted drugs for the treatment of cancer, today announced that it has closed on its previously announced private placement with certain institutional investors that is expected to result in gross proceeds of up to $102.9 million, including gross proceeds of $24.5 million which the Company received at closing. The financing was led by Rosalind Advisors with participation from AIGH Capital, ADAR1, Second Line, Nantahala Capital, AuGC, and other new and existing institutional investors.
Quick answer
Cellectar raised $103 Million in a Post-IPO Equity round, dated September 11, 2023. Cellectar is based in Florham Park, New Jersey, United States.
- How much did Cellectar raise?
- Cellectar raised $103 Million in a Post-IPO Equity round on September 11, 2023.
- What does Cellectar do?
- Cellectar Biosciences is focused on the discovery and development of drugs for the treatment of cancer.
- Where is Cellectar based and how big is it?
- Cellectar is based in Florham Park, New Jersey, United States.
- Who are the decision-makers at Cellectar?
- Fundz holds 1 contact at Cellectar. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Pharmaceutical around the same time
Companies in the same sectors as Cellectar that raised within 45 days of this round, from Fundz verified event records.
- Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
- Azora Therapeutics, Inc. (DE) raised $4M (Seed) on October 19, 2023.
- Clene Nanomedicine raised $45M (Grant) on October 15, 2023.
- Acasti raised $7.5M (Post-IPO Equity) on September 26, 2023.
- Acasti raised $7.5M on September 25, 2023.
- Scinai Immunotherapeutics Ltd raised $1.3M (Seed) on September 19, 2023.
Who to call at Cellectar, and when
A new round usually means Cellectar is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cellectar raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cellectar, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cellectar. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cellectar raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cellectar raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.